Original document(62 pages)  中文版
    The invention relates to substituted N-cyclohexyl heterocycles as well as the physiologically acceptable salts and physiologically functional derivatives thereof, methods for the production thereof, and the use thereof as medicaments. Disclosed are compounds of formula (I), wherein the radicals have the indicated meanings, the physiologically acceptable salts thereof, and methods for the production thereof. Said compounds cause weight loss in mammals, for example, and are suitable for the prevention and treatment of obesity and diabetes, for instance.
Application Number
申请号
200580009134 Application Date
申请日
2005.01.25
Title 名称 Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect
Publication Number
公开号
1934090 Publication Date
公开日
2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D233/70;A61K31/4166;A61P3/04;A61P3/10;C07D401/04;C07D403/08;C07D401/08
Applicant(s) Name
申请人
Aventis Pharma GmbH
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 huangge sheng jiashi cong
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.